Steps to complete the survey:
1. Click on Sign In button and login/register from your account.
2. Click on Participate button, and you will be directed to the survey page.
3. Fill in the survey and submit.
Hypercholesterolemia is a disorder of lipoprotein metabolism characterized by an increased plasma level of LDL-C concentrations. Statins remain the frontline treatment option in the management of hypercholesterolemia. Rosuvastatin has been evaluated in many trials and has proved efficacy as well as safety in terms of lipid reduction.
The scientific survey is being conducted to assemble the physician perspective and evolving recommendations related to prescribing rosuvastatin in the treatment of Hypercholesterolemia.
This survey can help to derive opinions from well-known HCP's regarding the various benefits above lipid reduction like reduction in Cardiovascular events can also assist in an unbiased approach in timely selecting the appropriate therapeutic regimen in the best interest of the patients.
Course objectives:
1. To derive the results related to efficacy, safety of rosuvastatin use in clinical practice thereby making an unbiased approach in decision making and suitably selecting the anti-lipid therapy in hypercholesterolemia patients.
2. To collect thoughts, opinions, and comments from the desired reputed targeted Drs. The valuable feedback derived shall serve as a baseline to measure and establish a new horizon as well as compare results over time.
3.To derive results related to use of rosuvastatin in high cholesterol patients along with other comorbidities and the quality of life improvement in their patients.